Results 211 to 220 of about 162,220 (306)

Biomarkers of lung congestion and injury in acute heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi   +9 more
wiley   +1 more source

Advanced interstitial lung disease: Evidence-based management and clinical approach. [PDF]

open access: yesSarcoidosis Vasc Diffuse Lung Dis
Kattih Z   +3 more
europepmc   +1 more source

Increased calcification by erythrophagocytosis in aortic valvular interstitial cells

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1469-1473, April 2025.
Abstract Background Calcific aortic valve disease (CAVD) progresses over time to severe aortic stenosis and eventually heart failure. Recent evidence indicates that intraleaflet haemorrhage (ILH) strongly promotes CAVD progression. However, it remains poorly understood how it mechanistically contributes to valvular calcification.
Zihan Qin   +3 more
wiley   +1 more source

The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis. [PDF]

open access: yesArthritis Res Ther
Zheng S   +16 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

AI-powered evaluation of lung function for diagnosis of interstitial lung disease. [PDF]

open access: yesThorax
Gompelmann D   +20 more
europepmc   +1 more source

Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1374-1385, April 2025.
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu   +9 more
wiley   +1 more source

Factors affecting quality of life in connective tissue disease-related interstitial lung disease. [PDF]

open access: yesPLoS One
O'Hare LL   +6 more
europepmc   +1 more source

Home‐operated ultrasound exam for detection of worsening heart failure (HOUSE‐HF)

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Acute decompensated heart failure (ADHF) is associated with a high degree of morbidity and mortality. Dynamic lung ultrasound artefact called B‐lines can be obtained at the bedside and directly correlate with pulmonary vascular congestion. Obtaining patient‐performed lung ultrasound images in the outpatient setting is novel.
Stuart B. Prenner   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy